Xuxin (HongKong) Biotechnology Co., Limited
- Biotech or pharma, therapeutic R&D
Xu Xin (Hong Kong) Biotechnology Co., a subsidiary of RECORNA Bio., is a high-tech enterprise located in the Hong Kong Science Park, specialized on AI-driven groundbreaking RNA-targeted therapies.
Our platform technologies support drug targeting strategies that restore, modulate, or upregulate the function and expression levels of target proteins, and they can be applied to diseases with diverse pathogenesis.
These top-notch innovations allow us to overcome the limitations of traditional small-molecule and biologic drugs, and to address key therapeutic challenges such as genetic diseases caused by single-point mutation and frameshift mutation, and general diseases, e.g., CVD, metabolic diseases and Immuno-oncology diseases. Using endogenous ADAR enzymes, our drug molecules can achieve precise and efficient editing while readily delivered to the body. At the same time, our design strategies ensure avoiding the irreversible off-target safety risks associated with DNA-level gene editing.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}